Form 4: Protagonist Therapeutics CFO Sells Shares to Cover Tax Obligations
SEC Form 4
Asif Ali, CFO of Protagonist Therapeutics, sold 1,234 shares of common stock on April 18, 2024, to cover tax withholding obligations.
Summary
- On April 18, 2024, Asif Ali, the Chief Financial Officer of Protagonist Therapeutics, sold 1,234 shares of the company's common stock.
- The sale was executed at a price of $25.11 per share.
- The transaction was conducted to cover tax withholding obligations incurred upon the settlement of restricted stock units.
- Following the transaction, Asif Ali directly owns 37,163 shares of Protagonist Therapeutics.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a routine transaction to cover tax obligations. It doesn't indicate any positive or negative outlook for the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.
Key Dates
| Date | Description |
|---|---|
| 04/18/2024 | Date of the transaction: Asif Ali sold 1,234 shares of Protagonist Therapeutics common stock. |
| 04/19/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.